Patent: 9,526,915
✉ Email this page to a colleague
Summary for Patent: 9,526,915
Title: | Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase |
Abstract: | Disclosed herein are methods of inhibiting proliferation of a cancer cell or inducing apoptosis of a cancer cell, which does not overexpress N--CoR. Also disclosed herein are methods of inhibiting proliferation or inducing apoptosis of a cancer cell that overexpresses TCTP and methods for determining whether a compound is effective in inducing cell death. |
Inventor(s): | Kovach; John S. (East Setauket, NY) |
Assignee: | |
Application Number: | 13/870,763 |
Patent Claims: | see list of patent claims |
Details for Patent 9,526,915
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2028-08-01 |
Amgen, Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | 06/01/1989 | ⤷ Try a Trial | 2028-08-01 |
Amgen, Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | ⤷ Try a Trial | 2028-08-01 | |
Amgen, Inc. | PROCRIT | epoetin alfa | Injection | 103234 | ⤷ Try a Trial | 2028-08-01 | |
Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2028-08-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |